Market news

Illumina's AI strategy is reshaping the investment case. See how sequencing, biological data, and drug-discovery partnerships could change what drives the company next.

Key Stats for Illumina StockCurrent Price: $273. 90Target Price (Mid): ~$412Street Target: ~$203Potential Total Return: ~50%Annualized IRR: ~10% / yearWhat Happened?Illumina (ILMN) closed at $273.

Index removal puts Illumina in focus Illumina (ILMN) has been removed from the Russell Small Cap Value Index, an index reshuffle that can prompt mechanical selling and raise fresh questions about how the stock is being valued today. The index removal comes at a time when Illumina’s momentum is already strong, with a 1-day share price return of 7.25%, a 30-day share price return of 21.82% and a year-to-date share price return of 103.87%. These feed into a 1-year total shareholder return of...

ILMN's 94.9% YTD rally reflects strong sequencing growth, clinical adoption and a raised 2026 outlook despite China headwinds.

Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 5.48% on an annualized basis producing an average annual return of 14.65%. Currently, Illumina has a market capitalization of $37.84 billion.

Key TakeawaysYear-Long Surge: Illumina stock has climbed 133% over the past year, closing at $240 on September 18, 2026, up from roughly $103 twelve months earlier. Street Split: Illumina stock carries 7 buy ratings, 4 outperforms, 6 holds, 3 underperforms and 1 sell, and the $203 mean target now sits 15% below where shares trade, a reversal from a year ago when the target sat above the price.

Illumina (ILMN) stock is up 64% post-GRAIL spin-off.

Bloom Energy (BE), Everpure (P) and Illumina (ILMN) will join the S&P 500, effective before the open

Illumina, Inc. (NASDAQ:ILMN) and Everpure, Inc. (NYSE:P) are set to join the S&P 500 as part of the index’s quarterly rebalancing, with the changes taking effect before the market opens on September 21. Both companies will replace Builders FirstSource and The Trade Desk. Both companies are moving up from the S&P MidCap 400. The change […]

S&P index rebalance Sept. 21, 2026: S&P 500 adds Bloom Energy, Everpure & Illumina; S&P 100 adds Dell, PANW & more—see key impacts.

The fuel-cell company will join on Sept. 21, along with Illumina and Everpure.

In September 2026, Novacyt S.A. announced it had entered into a five-year Master Collaboration Agreement with Illumina, creating a framework for separate project-based deals in product development and commercial collaboration. This structure gives Illumina a flexible way to tap Novacyt’s complementary expertise without committing upfront capital to specific programs, potentially broadening future genomic applications. We’ll now examine how this new Master Collaboration framework with...

S&P Dow Jones Indices will make the following changes to the S&P 500, S&P 100, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 21, 2026, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.

Bloom Energy surges after joining the S&P 500 with Illumina and Everpure—see index additions, deletions, and market moves.

Bloom Energy (BE) Illumina and Everpure will join the S&P 500 in the latest quarterly rebalance, S&P

Opportunities center on NGS, metagenomic profiling, portable field tests and cloud analytics, driven by viral outbreaks, precision agriculture, biosecurity and demand for early detection. Plant Virome Diagnostics Market Plant Virome Diagnostics Market Dublin, Sept. 01, 2026 (GLOBE NEWSWIRE) -- The "Plant Virome Diagnostics Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global plant virome diagnostics market is experiencing strong growth as agricultural producers, re

Looking back on life sciences tools & services stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Illumina (NASDAQ:ILMN) and its peers.

Illumina (ILMN) has entered a new US$1.0b senior unsecured five year revolving credit facility that replaces its prior agreement, giving the company fresh financing flexibility without any current borrowings reported under the line. Illumina’s new revolving credit facility arrives during a strong run in the stock, with a 7 day share price return of 19.49% and a 90 day share price return of 49.82%. The 1 year total shareholder return of 127.88% contrasts with a 5 year total shareholder return...

Illumina (NasdaqGS: ILMN) has entered into a new US$1b unsecured revolving credit facility, replacing its previous agreement. The new facility provides updated covenants and increased flexibility for Illumina's future financing plans. The credit line is expected to serve as a liquidity backstop and support the company's broader capital structure decisions. Consider reviewing other companies with meaningful financing flexibility and balance sheet capacity in related areas through 38 power...

Illumina's Q2 2026 beat raised guidance and targets margin expansion & buybacks. Click here to read more on ILMN.

Illumina, Qnity Electronics and nVent Electric lead Zacks' latest Strong Buy picks as markets eye inflation, rates and global risks.